News
Fidelis Insurance Holdings Limited (NYSE:FIHL) Q3 2023 Earnings Call Transcript November 21, 2023 8:00 AM ET Company Participants Jillian Benson – Group Head of...
Hi, what are you looking for?
IntelTEXTA
IntelTEXTA
News
This article was written by Follow Michael Kramer is the founder of Mott Capital, and is a long-only investor who focuses on macro themes...
News
Seeking Alpha’s Calls Of The Week Nike (NKE): Why Investors Should Still ‘Just Do It.’ Realty Income (O) Is In The Buy Column For...
News
This article was written by Follow I have approximately 13 years of experience trading and researching, specifically relating to central banking and credit cycles....
News
As everyone knows, Monster Beverage (NASDAQ:MNST) has been a stock that has given spectacular returns to its shareholders so far for decades. It has...
News
If you’re like me, you rarely transact in cash anymore. I can probably count on one hand how many times I use physical cash...
News
Elevator Pitch I stick with my Hold rating for Cushman & Wakefield plc (NYSE:CWK) shares. With my previous article for CWK published on September...
News
Currently I am covering the biggest airplane manufacturers in the world. I am also covering various airlines and lessors that are the customers for...
News
BiomX logo (BiomX website) BiomX Inc. (NYSE:PHGE) is a clinical-stage biotech company that develops bacteriophage (“phage”) cocktails to treat various diseases utilizing its next-generation...
News
Back in March, I placed a “Sell” rating on Beyond Meat (NASDAQ:BYND), saying management greatly misread demand for its product. I reiterated my “Sell”...
News
I have to confess that between my husband and me, we are not very “street smart” when it comes to raising teenagers. I’m embarrassed...
News
X Financial (NYSE:XYF) Q3 2023 Results Conference Call November 22, 2023 9:00 PM ET Company Participants Victoria Yu – Investor Relations Kan Li –...
News
Investment Thesis In my opinion, Bristol-Myers Squibb (NYSE:BMY) stands at a critical juncture. My forthcoming analysis contends that the company’s valuation and future market...
